An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)

Background: ATM, the protein defective in the human genetic disorder, ataxia-telangiectasia (A-T) plays a central role in response to DNA double-strand breaks (DSBs) and in protecting the cell against oxidative stress. We showed that A-T cells are hypersensitive to metabolic stress which can be acco...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A.J. Yeo, G.N. Subramanian, K.L. Chong, M. Gatei, R.G. Parton, D. Coman, M.F. Lavin
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
ATM
Acceso en línea:https://doaj.org/article/25d6e71a108248368e69a3aaa026e679
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:25d6e71a108248368e69a3aaa026e679
record_format dspace
spelling oai:doaj.org-article:25d6e71a108248368e69a3aaa026e6792021-11-14T04:32:37ZAn anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)2212-877810.1016/j.molmet.2021.101354https://doaj.org/article/25d6e71a108248368e69a3aaa026e6792021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2212877821002015https://doaj.org/toc/2212-8778Background: ATM, the protein defective in the human genetic disorder, ataxia-telangiectasia (A-T) plays a central role in response to DNA double-strand breaks (DSBs) and in protecting the cell against oxidative stress. We showed that A-T cells are hypersensitive to metabolic stress which can be accounted for by a failure to exhibit efficient endoplasmic reticulum (ER)-mitochondrial signalling and Ca2+ transfer in response to nutrient deprivation resulting in mitochondrial dysfunction. The objective of the current study is to use an anaplerotic approach using the fatty acid, heptanoate (C7), a metabolic product of the triglyceride, triheptanoin to correct the defect in ER-mitochondrial signalling and enhance cell survival of A-T cells in response to metabolic stress. Methods: We treated control cells and A-T cells with the anaplerotic agent, heptanoate to determine their sensitivity to metabolic stress induced by inhibition of glycolysis with 2- deoxyglucose (2DG) using live-cell imaging to monitor cell survival for 72 h using the Incucyte system. We examined ER-mitochondrial signalling in A-T cells exposed to metabolic stress using a suite of techniques including immunofluorescence staining of Grp75, ER-mitochondrial Ca2+ channel, the VAPB-PTPIP51 ER-mitochondrial tether complexes as well as proximity ligation assays between Grp75-IP3R1 and VAPB1-PTPIP51 to establish a functional interaction between ER and mitochondria. Finally, we also performed metabolomic analysis using LC-MS/MS assay to determine altered levels of TCA intermediates A-T cells compared to healthy control cells. Results: We demonstrate that heptanoate corrects all aspects of the defective ER-mitochondrial signalling observed in A-T cells. Heptanoate enhances ER-mitochondrial contacts; increases the flow of calcium from the ER to the mitochondrion; restores normal mitochondrial function and mitophagy and increases the resistance of ATM-deficient cells and cells from A-T patients to metabolic stress-induced killing. The defect in mitochondrial function in ATM-deficient cells was accompanied by more reliance on aerobic glycolysis as shown by increased lactate dehydrogenase A (LDHA), accumulation of lactate, and reduced levels of both acetyl CoA and ATP which are all restored by heptanoate. Conclusions: We conclude that heptanoate corrects metabolic stress in A-T cells by restoring ER-mitochondria signalling and mitochondrial function and suggest that the parent compound, triheptanoin, has immense potential as a novel therapeutic agent for patients with A-T.A.J. YeoG.N. SubramanianK.L. ChongM. GateiR.G. PartonD. ComanM.F. LavinElsevierarticleAtaxia-telangiectasiaATMNutrient deprivationEndoplasmic reticulum–mitochondrial interactionMitochondrial dysfunctionHeptanoate (C7)Internal medicineRC31-1245ENMolecular Metabolism, Vol 54, Iss , Pp 101354- (2021)
institution DOAJ
collection DOAJ
language EN
topic Ataxia-telangiectasia
ATM
Nutrient deprivation
Endoplasmic reticulum–mitochondrial interaction
Mitochondrial dysfunction
Heptanoate (C7)
Internal medicine
RC31-1245
spellingShingle Ataxia-telangiectasia
ATM
Nutrient deprivation
Endoplasmic reticulum–mitochondrial interaction
Mitochondrial dysfunction
Heptanoate (C7)
Internal medicine
RC31-1245
A.J. Yeo
G.N. Subramanian
K.L. Chong
M. Gatei
R.G. Parton
D. Coman
M.F. Lavin
An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
description Background: ATM, the protein defective in the human genetic disorder, ataxia-telangiectasia (A-T) plays a central role in response to DNA double-strand breaks (DSBs) and in protecting the cell against oxidative stress. We showed that A-T cells are hypersensitive to metabolic stress which can be accounted for by a failure to exhibit efficient endoplasmic reticulum (ER)-mitochondrial signalling and Ca2+ transfer in response to nutrient deprivation resulting in mitochondrial dysfunction. The objective of the current study is to use an anaplerotic approach using the fatty acid, heptanoate (C7), a metabolic product of the triglyceride, triheptanoin to correct the defect in ER-mitochondrial signalling and enhance cell survival of A-T cells in response to metabolic stress. Methods: We treated control cells and A-T cells with the anaplerotic agent, heptanoate to determine their sensitivity to metabolic stress induced by inhibition of glycolysis with 2- deoxyglucose (2DG) using live-cell imaging to monitor cell survival for 72 h using the Incucyte system. We examined ER-mitochondrial signalling in A-T cells exposed to metabolic stress using a suite of techniques including immunofluorescence staining of Grp75, ER-mitochondrial Ca2+ channel, the VAPB-PTPIP51 ER-mitochondrial tether complexes as well as proximity ligation assays between Grp75-IP3R1 and VAPB1-PTPIP51 to establish a functional interaction between ER and mitochondria. Finally, we also performed metabolomic analysis using LC-MS/MS assay to determine altered levels of TCA intermediates A-T cells compared to healthy control cells. Results: We demonstrate that heptanoate corrects all aspects of the defective ER-mitochondrial signalling observed in A-T cells. Heptanoate enhances ER-mitochondrial contacts; increases the flow of calcium from the ER to the mitochondrion; restores normal mitochondrial function and mitophagy and increases the resistance of ATM-deficient cells and cells from A-T patients to metabolic stress-induced killing. The defect in mitochondrial function in ATM-deficient cells was accompanied by more reliance on aerobic glycolysis as shown by increased lactate dehydrogenase A (LDHA), accumulation of lactate, and reduced levels of both acetyl CoA and ATP which are all restored by heptanoate. Conclusions: We conclude that heptanoate corrects metabolic stress in A-T cells by restoring ER-mitochondria signalling and mitochondrial function and suggest that the parent compound, triheptanoin, has immense potential as a novel therapeutic agent for patients with A-T.
format article
author A.J. Yeo
G.N. Subramanian
K.L. Chong
M. Gatei
R.G. Parton
D. Coman
M.F. Lavin
author_facet A.J. Yeo
G.N. Subramanian
K.L. Chong
M. Gatei
R.G. Parton
D. Coman
M.F. Lavin
author_sort A.J. Yeo
title An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
title_short An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
title_full An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
title_fullStr An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
title_full_unstemmed An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
title_sort anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (a-t)
publisher Elsevier
publishDate 2021
url https://doaj.org/article/25d6e71a108248368e69a3aaa026e679
work_keys_str_mv AT ajyeo ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT gnsubramanian ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT klchong ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT mgatei ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT rgparton ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT dcoman ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT mflavin ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT ajyeo anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT gnsubramanian anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT klchong anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT mgatei anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT rgparton anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT dcoman anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
AT mflavin anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat
_version_ 1718429945359761408